Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:lysophosphatidylcholine
go back to main search page
Accession:CHEBI:60479 term browser browse the term
Definition:An acylglycerophosphocholine resulting from partial hydrolysis of a phosphatidylcholine, which removes one of the fatty acyl groups. The structure is depicted in the image where R1 = acyl, R2 = H or where R1 = H, R2 = acyl.
Synonyms:related_synonym: Formula=C9H19NO7PR;   SMILES=[C@](CO*)(O*)([H])COP(OCC[N+](C)(C)C)(=O)[O-];   lysophosphatidylcholines;   monoacylglycero-3-phosphocholine
 alt_id: MESH:D008244
 xref_mesh: MESH:D008244



show annotations for term's descendants           Sort by:
 
lysophosphatidylcholine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Arntl aryl hydrocarbon receptor nuclear translocator-like affects abundance ISO ARNTL gene mutant form affects the abundance of Lysophosphatidylcholines CTD PMID:27056296 NCBI chr 1:167,331,756...167,430,235
Ensembl chr 1:167,331,633...167,430,231
JBrowse link
G Cav1 caveolin 1 multiple interactions
increases expression
ISO alpha-Tocopherol inhibits the reaction [Lysophosphatidylcholines results in increased expression of CAV1 mRNA]; quercetin 3-O-glucuronide inhibits the reaction [Lysophosphatidylcholines results in increased expression of CAV1 mRNA]; Quercetin inhibits the reaction [Lysophosphatidylcholines results in increased expression of CAV1 mRNA]; Quercetin inhibits the reaction [Lysophosphatidylcholines results in increased expression of CAV1 protein]
Lysophosphatidylcholines results in increased expression of CAV1 mRNA; Lysophosphatidylcholines results in increased expression of CAV1 protein
CTD PMID:27257344 NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
JBrowse link
G Enpp2 ectonucleotide pyrophosphatase/phosphodiesterase 2 multiple interactions ISO [[Capsaicin results in increased chemical synthesis of Lysophosphatidylcholines] which results in increased secretion of Lysophosphatidylcholines] promotes the reaction [ENPP2 results in increased chemical synthesis of lysophosphatidic acid]; [ENPP2 protein co-treated with Lysophosphatidylcholines] results in increased chemical synthesis of lysophosphatidic acid CTD PMID:19014389 NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827
JBrowse link
G Enpp7 ectonucleotide pyrophosphatase/phosphodiesterase 7 increases hydrolysis ISO ENPP7 protein results in increased hydrolysis of Lysophosphatidylcholines CTD PMID:12885774 NCBI chr10:104,242,223...104,246,589
Ensembl chr10:104,242,223...104,246,589
JBrowse link
G Fscn1 fascin actin-bundling protein 1 increases expression ISO Lysophosphatidylcholines results in increased expression of FSCN1 mRNA CTD PMID:22102721 NCBI chr12:11,597,042...11,610,183
Ensembl chr12:11,597,048...11,610,211
JBrowse link
G Gja1 gap junction protein, alpha 1 increases ubiquitination
multiple interactions
EXP Lysophosphatidylcholines results in increased ubiquitination of GJA1 protein
Lysophosphatidylcholines affects the localization of and results in increased phosphorylation of GJA1 protein; PRKCE affects the reaction [Lysophosphatidylcholines results in increased phosphorylation of GJA1 protein]
CTD PMID:23973256 NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
JBrowse link
G Hmox1 heme oxygenase 1 increases expression ISO Lysophosphatidylcholines results in increased expression of HMOX1 mRNA CTD PMID:9808084 NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
JBrowse link
G Icam1 intercellular adhesion molecule 1 increases expression
multiple interactions
ISO Lysophosphatidylcholines results in increased expression of ICAM1 mRNA
quercetin 3-O-glucuronide inhibits the reaction [Lysophosphatidylcholines results in increased expression of ICAM1 mRNA]; Quercetin inhibits the reaction [Lysophosphatidylcholines results in increased expression of ICAM1 mRNA]
CTD PMID:27257344 NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
JBrowse link
G Lama3 laminin subunit alpha 3 increases expression ISO Lysophosphatidylcholines results in increased expression of LAMA3 mRNA CTD PMID:15541073 NCBI chr18:3,523,168...3,751,722
Ensembl chr18:3,523,133...3,751,353
JBrowse link
G Lamb3 laminin subunit beta 3 increases expression ISO Lysophosphatidylcholines results in increased expression of LAMB3 mRNA CTD PMID:15541073 NCBI chr13:104,833,810...104,875,405
Ensembl chr13:104,833,873...104,875,405
JBrowse link
G Lamc2 laminin subunit gamma 2 increases expression ISO Lysophosphatidylcholines results in increased expression of LAMC2 mRNA CTD PMID:15541073 NCBI chr13:65,284,664...65,344,200
Ensembl chr13:65,284,664...65,344,200
JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions
increases phosphorylation
EXP 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Lysophosphatidylcholines results in increased phosphorylation of MAPK1 protein]; resveratrol inhibits the reaction [Lysophosphatidylcholines results in increased phosphorylation of MAPK1 protein] CTD PMID:20564508 NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions
increases phosphorylation
EXP 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Lysophosphatidylcholines results in increased phosphorylation of MAPK3 protein]; resveratrol inhibits the reaction [Lysophosphatidylcholines results in increased phosphorylation of MAPK3 protein] CTD PMID:20564508 NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
JBrowse link
G Mfsd2a major facilitator superfamily domain containing 2A increases transport ISO MFSD2A results in increased transport of Lysophosphatidylcholines CTD PMID:26005865 NCBI chr 5:135,225,801...135,240,744
Ensembl chr 5:135,225,816...135,240,690
JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions
increases expression
EXP 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Lysophosphatidylcholines results in increased expression of NOS2 mRNA]; Resveratrol inhibits the reaction [Lysophosphatidylcholines results in increased expression of NOS2 mRNA] CTD PMID:20564508 NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
JBrowse link
G Nos3 nitric oxide synthase 3 multiple interactions
decreases expression
EXP 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Lysophosphatidylcholines results in decreased expression of NOS3 mRNA]; resveratrol inhibits the reaction [Lysophosphatidylcholines results in decreased expression of NOS3 mRNA] CTD PMID:20564508 NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
JBrowse link
G Nr5a2 nuclear receptor subfamily 5, group A, member 2 multiple interactions ISO [NR5A2 gene mutant form results in increased susceptibility to Dietary Fats] which results in increased abundance of Lysophosphatidylcholines CTD PMID:29515023 NCBI chr13:48,313,634...48,433,494
Ensembl chr13:48,316,301...48,433,326
JBrowse link
G Pah phenylalanine hydroxylase multiple interactions ISO Lysophosphatidylcholines results in increased activity of [PAH protein binds to PAH protein binds to PAH protein binds to PAH protein] CTD PMID:19367645 NCBI chr 7:21,933,179...21,998,134
Ensembl chr 7:21,933,179...21,998,130
JBrowse link
G Prkce protein kinase C, epsilon multiple interactions EXP PRKCE affects the reaction [Lysophosphatidylcholines results in increased phosphorylation of GJA1 protein] CTD PMID:23973256 NCBI chr 6:7,965,048...8,451,966
Ensembl chr 6:7,965,048...8,451,719
JBrowse link
G Ptgs1 prostaglandin-endoperoxide synthase 1 decreases expression
multiple interactions
EXP Lysophosphatidylcholines results in decreased expression of PTGS1 mRNA
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Lysophosphatidylcholines results in decreased expression of PTGS1 mRNA]; resveratrol inhibits the reaction [Lysophosphatidylcholines results in decreased expression of PTGS1 mRNA]
CTD PMID:20564508 NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions
increases expression
EXP 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Lysophosphatidylcholines results in increased expression of PTGS2 mRNA]; resveratrol inhibits the reaction [Lysophosphatidylcholines results in increased expression of PTGS2 mRNA] CTD PMID:20564508 NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188
JBrowse link
G Tp53 tumor protein p53 multiple interactions ISO [TP53 protein mutant form results in increased susceptibility to Niclosamide] which results in increased abundance of Lysophosphatidylcholines CTD PMID:30258081 NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
JBrowse link
G Trpc5 transient receptor potential cation channel, subfamily C, member 5 multiple interactions ISO Lysophosphatidylcholines promotes the reaction [TRPC5 protein results in increased transport of Calcium]; resveratrol inhibits the reaction [Lysophosphatidylcholines promotes the reaction [TRPC5 protein results in increased transport of Calcium]] CTD PMID:21127073 NCBI chr  X:107,946,163...108,230,978
Ensembl chr  X:107,939,131...108,230,991
JBrowse link
G Vcam1 vascular cell adhesion molecule 1 increases expression ISO Lysophosphatidylcholines results in increased expression of VCAM1 mRNA CTD PMID:27257344 NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
JBrowse link
1-O-oleoyl-sn-glycero-3-phosphocholine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Nr5a2 nuclear receptor subfamily 5, group A, member 2 multiple interactions ISO [NR5A2 gene mutant form results in increased susceptibility to Dietary Fats] which results in increased abundance of 1-oleoyl lysophosphatidylcholine CTD PMID:29515023 NCBI chr13:48,313,634...48,433,494
Ensembl chr13:48,316,301...48,433,326
JBrowse link
G Smad3 SMAD family member 3 decreases abundance ISO SMAD3 protein results in decreased abundance of 1-oleoyl lysophosphatidylcholine CTD PMID:23034213 NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
JBrowse link
1-stearoyl-sn-glycero-3-phosphocholine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Lipc lipase C, hepatic type multiple interactions ISO [LIPC gene mutant form co-treated with LIPG gene mutant form] results in increased abundance of stearoyl alpha-lysolecithin CTD PMID:24777581 NCBI chr 8:71,509,633...71,635,663
Ensembl chr 8:71,509,635...71,635,464
JBrowse link
G Lipg lipase G, endothelial type multiple interactions ISO [LIPC gene mutant form co-treated with LIPG gene mutant form] results in increased abundance of stearoyl alpha-lysolecithin CTD PMID:24777581 NCBI chr18:68,514,923...68,536,105
Ensembl chr18:68,514,923...68,536,260
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19800
    role 19751
      biological role 19751
        osmolyte 2053
          glycerol 1776
            glycerolipid 268
              glycerophospholipid 204
                glycerophosphocholine 119
                  lysophosphatidylcholine 27
                    1-O-acyl-sn-glycero-3-phosphocholine(1+) + 0
                    1-acylglycerophosphocholine(1+) + 0
                    1-lysophosphatidylcholine + 0
                    2-acylglycerophosphocholine + 0
                    2-lysophosphatidylcholine + 4
                    LysoPC(18:3(6Z,9Z,12Z)) 0
                    LysoPC(18:3(9Z,12Z,15Z)) 0
                    LysoPC(18:4(6Z,9Z,12Z,15Z)) 0
                    LysoPC(20:5(5Z,8Z,11Z,14Z,17Z)) 0
                    LysoPC(22:1(13Z)) 0
                    LysoPC(22:2(13Z,16Z)) 0
                    LysoPC(24:1(15Z)) 0
                    acyl-sn-glycero-3-phosphocholine + 4
                    lysophosphatidylcholine 12:0 0
                    lysophosphatidylcholine 14:0 + 0
                    lysophosphatidylcholine 14:1 + 0
                    lysophosphatidylcholine 14:2 0
                    lysophosphatidylcholine 15:0 + 0
                    lysophosphatidylcholine 15:1 0
                    lysophosphatidylcholine 15:2 0
                    lysophosphatidylcholine 16:0 + 0
                    lysophosphatidylcholine 16:1 + 0
                    lysophosphatidylcholine 16:2 0
                    lysophosphatidylcholine 17:0 + 0
                    lysophosphatidylcholine 17:1 + 0
                    lysophosphatidylcholine 18:0 + 2
                    lysophosphatidylcholine 18:1 + 2
                    lysophosphatidylcholine 18:2 + 0
                    lysophosphatidylcholine 18:3 + 0
                    lysophosphatidylcholine 18:4 + 0
                    lysophosphatidylcholine 19:0 + 0
                    lysophosphatidylcholine 20:0 + 0
                    lysophosphatidylcholine 20:1 + 0
                    lysophosphatidylcholine 20:2 + 0
                    lysophosphatidylcholine 20:3 + 0
                    lysophosphatidylcholine 20:4 + 0
                    lysophosphatidylcholine 20:5 + 0
                    lysophosphatidylcholine 22:0 0
                    lysophosphatidylcholine 22:1 0
                    lysophosphatidylcholine 22:2 0
                    lysophosphatidylcholine 22:4 + 0
                    lysophosphatidylcholine 22:5 + 0
                    lysophosphatidylcholine 22:6 + 0
                    lysophosphatidylcholine 24:0 + 0
                    lysophosphatidylcholine 24:1 0
                    lysophosphatidylcholine 26:0 0
                    lysophosphatidylcholine 26:1 0
                    lysophosphatidylcholine 28:0 0
                    lysophosphatidylcholine 28:1 0
                    lysophosphatidylcholine 6:0 + 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 19800
    subatomic particle 19799
      composite particle 19799
        hadron 19799
          baryon 19799
            nucleon 19799
              atomic nucleus 19799
                atom 19799
                  main group element atom 19698
                    p-block element atom 19698
                      chalcogen 19450
                        oxygen atom 19423
                          oxygen molecular entity 19423
                            hydroxides 19158
                              oxoacid 18472
                                pnictogen oxoacid 10733
                                  phosphorus oxoacid 9728
                                    phosphoric acids 8536
                                      phosphoric acid 8536
                                        phosphoric acid derivative 8242
                                          phosphate 8242
                                            organic phosphate 8241
                                              phospholipid 304
                                                glycerophospholipid 204
                                                  glycerophosphocholine 119
                                                    lysophosphatidylcholine 27
                                                      1-O-acyl-sn-glycero-3-phosphocholine(1+) + 0
                                                      1-acylglycerophosphocholine(1+) + 0
                                                      1-lysophosphatidylcholine + 0
                                                      2-acylglycerophosphocholine + 0
                                                      2-lysophosphatidylcholine + 4
                                                      LysoPC(18:3(6Z,9Z,12Z)) 0
                                                      LysoPC(18:3(9Z,12Z,15Z)) 0
                                                      LysoPC(18:4(6Z,9Z,12Z,15Z)) 0
                                                      LysoPC(20:5(5Z,8Z,11Z,14Z,17Z)) 0
                                                      LysoPC(22:1(13Z)) 0
                                                      LysoPC(22:2(13Z,16Z)) 0
                                                      LysoPC(24:1(15Z)) 0
                                                      acyl-sn-glycero-3-phosphocholine + 4
                                                      lysophosphatidylcholine 12:0 0
                                                      lysophosphatidylcholine 14:0 + 0
                                                      lysophosphatidylcholine 14:1 + 0
                                                      lysophosphatidylcholine 14:2 0
                                                      lysophosphatidylcholine 15:0 + 0
                                                      lysophosphatidylcholine 15:1 0
                                                      lysophosphatidylcholine 15:2 0
                                                      lysophosphatidylcholine 16:0 + 0
                                                      lysophosphatidylcholine 16:1 + 0
                                                      lysophosphatidylcholine 16:2 0
                                                      lysophosphatidylcholine 17:0 + 0
                                                      lysophosphatidylcholine 17:1 + 0
                                                      lysophosphatidylcholine 18:0 + 2
                                                      lysophosphatidylcholine 18:1 + 2
                                                      lysophosphatidylcholine 18:2 + 0
                                                      lysophosphatidylcholine 18:3 + 0
                                                      lysophosphatidylcholine 18:4 + 0
                                                      lysophosphatidylcholine 19:0 + 0
                                                      lysophosphatidylcholine 20:0 + 0
                                                      lysophosphatidylcholine 20:1 + 0
                                                      lysophosphatidylcholine 20:2 + 0
                                                      lysophosphatidylcholine 20:3 + 0
                                                      lysophosphatidylcholine 20:4 + 0
                                                      lysophosphatidylcholine 20:5 + 0
                                                      lysophosphatidylcholine 22:0 0
                                                      lysophosphatidylcholine 22:1 0
                                                      lysophosphatidylcholine 22:2 0
                                                      lysophosphatidylcholine 22:4 + 0
                                                      lysophosphatidylcholine 22:5 + 0
                                                      lysophosphatidylcholine 22:6 + 0
                                                      lysophosphatidylcholine 24:0 + 0
                                                      lysophosphatidylcholine 24:1 0
                                                      lysophosphatidylcholine 26:0 0
                                                      lysophosphatidylcholine 26:1 0
                                                      lysophosphatidylcholine 28:0 0
                                                      lysophosphatidylcholine 28:1 0
                                                      lysophosphatidylcholine 6:0 + 0
paths to the root